Consistent with efforts initiated during its first business term, Otsuka Holdings continued to reorganize its shareholdings in the fiscal year under review through an exchange of shares with Otsuka Chemical Co., Ltd., in July 2009.As a result, the Otsuka Group consisted of 77 companies as of March 31, 2010, including 65 consolidated subsidiaries and 12 affiliates consolidated under the equity-method with a combined number of 24,589 employees worldwide. As a truly global company, the Otsuka Group has a network of 145 subsidiaries, affiliates and related companies with about 39,000 employees worldwide.

Throughout Otsuka Group’s worldwide network, our companies are committed to take on challenges to improve human health worldwide. In this regard, the Group is active in two broad business segments: pharmaceuticals, including a full range of activities from diagnosis to treatment of medical disorders, and nutraceuticals* for the maintenance and improvement of daily health.

In meeting the challenge of discovering and developing original technologies and solutions, the Otsuka Group has established a proven global track record for the delivery of effective and beneficial products and services.

The main product in our pharmaceuticals business is ABILIFY, the world's first anti-psychotic agent that works as a dopamine partial agonist. ABILIFY has been approved for sale and use in more than 70 countries and regions, enabling patients worldwide to recover and return to a fulfilling life in society. Based on the concept of ″the IV solution you can drink,″ the Otsuka Group also markets Pocari Sweat in 16 countries and regions globally. A long-running top-seller, Pocari Sweat this year celebrates its 30th anniversary.

As a corporate group that is seeking to secure sustained growth, we recognize the critical need to become a ″company of true craftsmanship,″ skilled in the art of creating unique and unequaled products. Based on our corporate philosophy ″Otsuka-people creating new products for better health worldwide″, we strive to utilize our Group’s unique assets and skills to develop innovative and creative products which contribute to the healthy lives of people worldwide.

As we work towards achieving our aspirations and goals, we ask for your ongoing understanding and support.

Tatsuo Higuchi
President and Representative Director, CEO
Otsuka Holdings Co., Ltd.